Genia Licenses Nano-SBS Tech from Columbia, NIST; Plans 2014 Launch of Nanopore Sequencer | GenomeWeb

This article has been updated with additional information from Genia.

Genia Technologies is collaborating with scientists at Columbia University and Harvard University to develop a commercial single-molecule sequencer. The company has licensed a nanopore sequencing-by-synthesis technology developed by researchers at Columbia and the National Institute of Standards and Technology, which it plans to integrate with its nanopore chip platform, and is using polymerase fusion proteins developed at Harvard.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.